1 December is World AIDS Day, a day to recognise and address the ongoing disparities related to human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS).

This day serves as a powerful reminder of the ongoing battle against HIV/AIDS and the importance of awareness, education, and support for those affected.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

In the fight against HIV, testing plays a pivotal role, making it a central theme for this year’s World AIDS Day.

The impact of the coronavirus (Covid-19) pandemic initially slowed testing rates, but recent trends indicate a resilient comeback.

Public health initiatives, increased awareness, and accessible testing facilities have contributed to this positive shift.

According to GlobalData’s HIV Tests US Hospital Tracker database, the total market revenue for HIV tests sold to US hospitals was between $176.9m and $210.0m, meaning that between 19.3 million and 22.9 million tests were sold to US hospitals in 2022.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Based on this GlobalData report, Abbott holds the largest market share in the US at 35.3%, Roche comes in second with 28.2%, and Siemens Healthineers is third with 11.3%.

Additionally, the HIV test market has recovered from the decreased market revenue observed in 2020 due to the pandemic.

GlobalData’s HIV Tests US Hospital Tracker captures data from 20%-30% of all US hospitals, a substantial sample that can be subsequently extrapolated to provide insights into the entire US market.

Knowing someone’s HIV status empowers patients to make informed decisions about their health, and to take steps to protect themselves and their loved ones.

Early detection allows for timely medical intervention, which can significantly improve health outcomes.

Moreover, those who are aware of their HIV-positive status can take measures to prevent the transmission of the virus to others.